Mårten Wigstøl • 1960 • Oslo • 8 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
C COMBRA INVEST AS	Managing Director/CEO	-	-	33.33 % indirectly
C CIMON MEDICAL AS	Managing Director/CEO	3,011,005	-	3.44 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
B BARRACUDA INVEST AS	Chairman	2,042,800	-	100 % directly
C COMBRA INVEST AS	Board Member	-	-	33.33 % indirectly
B BRACOM AS	Chairman	158,176,540	53,317,240	18.82 % indirectly
L LYBE SCIENTIFIC AS	Chairman	3,550,849	-	4.87 % indirectly
C CIMON MEDICAL AS	Chairman	3,011,005	-	3.44 % indirectly
E ERAZE OSLO AS Closed	Board Member	5,935,639	-766,314	-

Last update: Apr 4, 2024

Related industries3

Direct relationships5

EG
Erling Geir Iversen1964
BRACOM AS, COMBRA INVEST AS
LA
Leif Arne Matre1962
BRACOM AS, COMBRA INVEST AS
JC
Jan Christian Sølve Ohlander Fosseidbråten1972
ERAZE OSLO AS
CM
Christina Myhre Lystad1991
ERAZE OSLO AS
GØ
Gisle Østereng1981
LYBE SCIENTIFIC AS

Shares owned by Mårten Wigstøl

Name	Share class	Total operating income	Total equity	Share
B BARRACUDA INVEST AS	Ordinære aksjer	2,042,800	0	100 % directly
C COMBRA INVEST AS		0	0	33.33 % indirectly
E ERAZE AS		5,715,371	0	28.09 % indirectly
B BRACOM AS		158,176,540	53,317,240	18.82 % indirectly
B BRACOM MICROTRENCHING AS Closed		29,016,781	532,344	18.82 % indirectly
L LYBE SCIENTIFIC AS		3,550,849	0	4.87 % indirectly
K KEIMON MEDICAL AS		500,000	-1,264,622	4.75 % indirectly
C CIMON MEDICAL AS		3,011,005	0	3.44 % indirectly
D DEFIBRIO AS		0	224,134,352	1.05 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025